Expression cloning of rat cDNA encoding UDP-galactose:GD2 beta1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1.
Using an anti-GD1b monoclonal antibody, expression cloning of a cDNA for the beta1,3-galactosyltransferase gene (EC 2.4.1.62) was performed. KF4C, mouse melanoma B16 transfected with polyoma T antigen gene, and GM2/GD2 synthase cDNA was used as a recipient cell line for the cDNA library transfection. A cDNA clone of GD3 synthase, pD3T-31 was co-transfected with a cDNA library prepared from rat brain RNA using the pcDNAI expression vector. The isolated cDNA clone pM1T-9 predicted a type II membrane protein with 4 amino acids of cytoplasmic domain, 21 amino acids of transmembrane region, and a large catalytic domain with 346 amino acids. Introduction of the cDNA clone into a mouse melanoma line B16 previously transfected with a GM2/GD2 synthase gene resulted in the neo-synthesis of GM1. Co-transfection of the cell line with pM1T-9 and a GD3 synthase cDNA resulted in the expression of GD1b as well as GM1. Moreover, introduction of pM1T-9 into L cell (lacking GM3 synthase), previously transfected with GM2/GD2 synthase gene, resulted in the definite expression of asialo-GM1. These results indicated that GD1b/GM1/GA1 synthases were identical, as previously suggested based on enzymological analysis. In Northern blots of the beta1, 3-galactosyltransferase gene with total RNA from various rat tissues, a 1.6-kilobase mRNA was strongly expressed in spleen, thymus, kidney, and testis. However, the expression level of the gene in the adult brain tissue was not especially high. On the other hand, this gene was expressed at high levels in the rat brain of embryonal day 12, and reached a peak at around birth, then fell to low level in the adult brain.
Miyazaki
H
H
Department of Biochemistry II, Nagoya University School of Medicine, 65 Tsuramai, Nagoya 466, Japan.
Fukumoto
S
S
Okada
M
M
Hasegawa
T
T
Furukawa
K
K
D000375:Aging / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000831:Animals, Newborn; D001483:Base Sequence; D001921:Brain / Q000201:enzymology*; D002240:Carbohydrate Sequence; D003001:Cloning, Molecular; D005314:Embryonic and Fetal Development; D005677:G(M1) Ganglioside / Q000096:biosynthesis* / Q000737:chemistry; D005700:Galactosyltransferases / Q000096:biosynthesis* / Q000737:chemistry / Q000378:metabolism; D005732:Gangliosides / Q000096:biosynthesis* / Q000737:chemistry; D018507:Gene Expression Regulation, Developmental; D015971:Gene Expression Regulation, Enzymologic; D015723:Gene Library; D006028:Glycosphingolipids / Q000096:biosynthesis* / Q000737:chemistry; D008297:Male; D008546:Melanoma, Experimental; D051379:Mice; D008969:Molecular Sequence Data; D009928:Organ Specificity; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D012799:Sialyltransferases / Q000096:biosynthesis / Q000378:metabolism; D013737:Testis / Q000201:enzymology; D014158:Transcription, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured
C011258:G(A1) ganglioside; D005732:Gangliosides; D006028:Glycosphingolipids; D012333:RNA, Messenger; D011994:Recombinant Proteins; C033851:ganglioside, GD1b; D005677:G(M1) Ganglioside; C108454:GD2 beta1,3-galactosyltransferase; D005700:Galactosyltransferases; D012799:Sialyltransferases; C043662:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase